Latest Market Entry News

Page 42 of 50
Wellnex Life Limited reports a robust 46% revenue increase and successful AIM listing, setting the stage for UK and European expansion.
Ada Torres
Ada Torres
13 May 2025
Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.
Ada Torres
Ada Torres
12 May 2025
Wide Open Agriculture secures $2.6 million via placement and plans a $500,000 Share Purchase Plan to fast-track its expansion into China and boost global sales of its lupin protein products.
Eva Park
Eva Park
9 May 2025
Orthocell has rapidly expanded its US distributor network for Remplir™, surpassing its target ahead of schedule and positioning itself for imminent sales in the $1.6 billion nerve repair market.
Ada Torres
Ada Torres
9 May 2025
Neuren Pharmaceuticals reports a robust 11% rise in DAYBUE™ US net sales for Q1 2025, alongside a 17% jump in royalty income, setting the stage for an anticipated European market entry in early 2026.
Victor Sage
Victor Sage
8 May 2025
CLINUVEL Pharmaceuticals has completed recruitment for its Phase III trial of SCENESSE® in vitiligo patients with darker skin types, setting the stage for first results in late 2026. Early clinical observations suggest promising repigmentation outcomes.
Ada Torres
Ada Torres
7 May 2025
Eden Innovations has secured its inaugural order from Holcim Mexico for EdenCretePz7, marking a strategic expansion into a major new market and extending its footprint within the global Holcim Group.
Maxwell Dee
Maxwell Dee
6 May 2025
Cardiex Limited has formally lodged its CONNEQT Pulse device with Australia's Therapeutics Goods Administration, marking a critical step toward regulatory approval and market expansion.
Ada Torres
Ada Torres
6 May 2025
Hazer Group has entered a binding six-year strategic alliance with global engineering leader KBR to exclusively market and license its methane pyrolysis technology, targeting the ammonia and methanol sectors. This partnership aims to accelerate commercialisation, expand global reach, and materially de-risk Hazer’s business plan.
Maxwell Dee
Maxwell Dee
5 May 2025
Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.
Ada Torres
Ada Torres
5 May 2025
Wide Open Agriculture Limited has clarified that its recently signed offtake and distribution agreement with Univar Solutions China carries no immediate financial impact, outlining a phased market entry and sales timeline.
Eva Park
Eva Park
1 May 2025
DUG Technology reported a 23% surge in software revenue and a 15% rise in EBITDA for FY25-Q3, underpinned by strong services order growth and strategic expansion into Brazil.
Sophie Babbage
Sophie Babbage
1 May 2025